Editorial: Antithrombotic management early after mechanical heart valve replacement.
Hering
Detlef
D
Piper
Cornelia
C
Horstkotte
Dieter
D
D000925:Anticoagulants / Q000627:therapeutic use; D013504:Cardiovascular Surgical Procedures; D004305:Dose-Response Relationship, Drug; D017984:Enoxaparin / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006350:Heart Valve Prosthesis; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D011182:Postoperative Care; D011486:Protein C / Q000502:physiology; D013923:Thromboembolism / Q000503:physiopathology / Q000517:prevention & control*; D014812:Vitamin K / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D017984:Enoxaparin; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D011486:Protein C; D014812:Vitamin K